#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Evan Ballantyne Email
Chief Financial Officer - Hansa Biopharma AB . Hansa Medical AB
Lund,
Locatione**************@hansabiopharma.com
Primary EmailHow to contact Evan Ballantyne
Join and see Evan's contact info for free!Current Roles
Employees:
207Revenue:
$32.1MAbout
Hansa Medical is a biopharmaceutical company developing novel immunomodulatory enzymes for transplantation and acute autoimmune diseases. The lead product, IdeS, is a proprietary antibody-degrading enzyme currently in late-stage clinical development for kidney transplant patients, with significant potential for further development in other solid organ transplants and in acute autoimmune indications. The company also has a strong pipeline of preclinical projects that may provide a second wave of potential drugs. Under the project name NiceR, novel immunoglobulin cleaving enzymes are developed for repeat dosing with the objective of applying the Hansa Medical technology in relapsing autoimmune diseases and oncology. Hansa Medical is based in Lund, Sweden, and its shares are listed on Nasdaq Stockholm (ticker: HMED).Hansa Medical AB Address
Scheelevägen 22Lund, null
Sweden